Cash Flow Statement

Daily Values

Growth Metrics

Assets (QoQ)Assets Growth (1y)Assets Growth (3y)Assets Growth (5y)Capital Expenditures (QoQ)Capital Expenditures Growth (1y)Capital Expenditures Growth (3y)Capital Expenditures Growth (5y)Cash & Equivalents (QoQ)Cash & Equivalents Growth (1y)Cash & Equivalents Growth (3y)Cash & Equivalents Growth (5y)Cash from Investing Activities (QoQ)Cash from Investing Activities Growth (1y)Cash from Investing Activities Growth (3y)Cash from Investing Activities Growth (5y)Cash from Operations (QoQ)Cash from Operations Growth (1y)Cash from Operations Growth (3y)Cash from Operations Growth (5y)EBIT (QoQ)EBIT Growth (1y)EBIT Growth (3y)EBIT Growth (5y)EBIT Margin (QoQ)EBIT Margin Growth (1y)EBIT Margin Growth (3y)EBIT Margin Growth (5y)EBITDA Margin (QoQ)EBITDA Margin Growth (1y)EBITDA Margin Growth (3y)EBITDA Margin Growth (5y)EBT (QoQ)EBT Growth (1y)EBT Growth (3y)EBT Growth (5y)EBT Margin (QoQ)EBT Margin Growth (1y)EBT Margin Growth (3y)EBT Margin Growth (5y)EPS (Basic) (QoQ)EPS (Basic) Growth (1y)EPS (Basic) Growth (3y)EPS (Basic) Growth (5y)EPS (Weighted Average and Diluted) (QoQ)EPS (Weighted Average and Diluted) Growth (1y)EPS (Weighted Average and Diluted) Growth (3y)EPS (Weighted Average and Diluted) Growth (5y)Enterprise Value (QoQ)Enterprise Value Growth (1y)Enterprise Value Growth (3y)Enterprise Value Growth (5y)FCF Margin (QoQ)FCF Margin Growth (1y)FCF Margin Growth (3y)FCF Margin Growth (5y)Free Cash Flow (QoQ)Free Cash Flow Growth (1y)Free Cash Flow Growth (3y)Free Cash Flow Growth (5y)Gross Margin (QoQ)Gross Margin Growth (1y)Gross Margin Growth (3y)Gross Margin Growth (5y)Gross Profit (QoQ)Gross Profit Growth (1y)Gross Profit Growth (3y)Gross Profit Growth (5y)Interest Coverage Ratio (QoQ)Interest Coverage Ratio Growth (1y)Interest Coverage Ratio Growth (3y)Interest Coverage Ratio Growth (5y)Net Cash Flow (QoQ)Net Cash Flow Growth (1y)Net Cash Flow Growth (3y)Net Cash Flow Growth (5y)Net Income (QoQ)Net Income Growth (1y)Net Income Growth (3y)Net Income Growth (5y)Net Income towards Common Stockholders (QoQ)Net Income towards Common Stockholders Growth (1y)Net Income towards Common Stockholders Growth (3y)Net Income towards Common Stockholders Growth (5y)Net Margin (QoQ)Net Margin Growth (1y)Net Margin Growth (3y)Net Margin Growth (5y)Operating Income (QoQ)Operating Income Growth (1y)Operating Income Growth (3y)Operating Income Growth (5y)Operating Margin (QoQ)Operating Margin Growth (1y)Operating Margin Growth (3y)Operating Margin Growth (5y)Profit After Tax (QoQ)Profit After Tax Growth (1y)Profit After Tax Growth (3y)Profit After Tax Growth (5y)Property, Plant & Equipment (Net) (QoQ)Property, Plant & Equipment (Net) Growth (1y)Property, Plant & Equipment (Net) Growth (3y)Property, Plant & Equipment (Net) Growth (5y)Return on Assets (QoQ)Return on Assets Growth (1y)Return on Assets Growth (3y)Return on Assets Growth (5y)Return on Capital Employed (QoQ)Return on Capital Employed Growth (1y)Return on Capital Employed Growth (3y)Return on Capital Employed Growth (5y)Return on Equity (QoQ)Return on Equity Growth (1y)Return on Equity Growth (3y)Return on Equity Growth (5y)Return on Invested Capital (QoQ)Return on Invested Capital Growth (1y)Return on Invested Capital Growth (3y)Return on Invested Capital Growth (5y)Return on Sales (QoQ)Return on Sales Growth (1y)Return on Sales Growth (3y)Return on Sales Growth (5y)Revenue (QoQ)Revenue Growth (1y)Revenue Growth (3y)Revenue Growth (5y)Share-based Compensation (QoQ)Share-based Compensation Growth (1y)Share-based Compensation Growth (3y)Share-based Compensation Growth (5y)Shareholder's Equity (QoQ)Shareholder's Equity Growth (1y)Shareholder's Equity Growth (3y)Shareholder's Equity Growth (5y)Tax Rate (QoQ)Tax Rate Growth (1y)Tax Rate Growth (3y)Tax Rate Growth (5y)Total Debt (QoQ)Total Debt Growth (1y)

Others

Biomerica (BMRA) EPS (Basic) (QoQ) (2011 - 2026)

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	152.82 Bn	146.17 Bn	6.27 Bn
2	Stryker	115.07 Bn	112.19 Bn	3.81 Bn
3	Medtronic	95.25 Bn	87.08 Bn	5.76 Bn
4	Boston Scientific	71.38 Bn	70.17 Bn	3.61 Bn
5	Edwards Lifesciences	51.08 Bn	47.41 Bn	1.29 Bn
6	Koninklijke Philips	29.38 Bn	26.07 Bn	2.07 Bn
7	Dexcom	28.84 Bn	27.72 Bn	750.30 Mn
8	GE HealthCare Technologies	28.56 Bn	26.49 Bn	1.98 Bn
9	Steris	20.71 Bn	20.30 Bn	697.10 Mn
10	Biomerica	7.12 Mn	5.78 Mn	-44,000.00

Historic Data

Download Data 🔒

Date	Value
Feb 28, 2026	2.22%
Nov 30, 2025	-59,470.73%
Aug 31, 2025	100.11%
May 31, 2025	-43.75%
Feb 28, 2025	-700.00%
Nov 30, 2024	90.48%
Aug 31, 2024	75.49%
May 31, 2024	-2,236.36%
Feb 29, 2024	-22.22%
Nov 30, 2023	-28.57%
Aug 31, 2023	30.00%
May 31, 2023	16.67%
Feb 28, 2023	0.00%
Nov 30, 2022	25.00%
Aug 31, 2022	-14.29%
May 31, 2022	-1,300.00%
Feb 28, 2022	88.89%
Nov 30, 2021	25.00%
Aug 31, 2021	7.69%
May 31, 2021	27.78%
Feb 28, 2021	-20.00%
Nov 30, 2020	6.25%
Aug 31, 2020	-128.57%
May 31, 2020	22.22%
Feb 29, 2020	-80.00%
Nov 30, 2019	0.00%
Aug 31, 2019	37.50%
May 31, 2019	-14.29%
Feb 28, 2019	-40.00%
Nov 30, 2018	0.00%
Aug 31, 2018	37.50%
May 31, 2018	-100.00%
Feb 28, 2018	-33.33%
Nov 30, 2017	-50.00%
Aug 31, 2017	50.00%
May 31, 2017	0.00%
Feb 28, 2017	-100.00%
Nov 30, 2016	-100.00%
Aug 31, 2016	93.75%
May 31, 2016	-700.00%
Feb 29, 2016	-100.00%
Nov 30, 2015	0.00%
Aug 31, 2015	-125.00%
May 31, 2015	300.00%
Feb 28, 2015	33.33%
Nov 30, 2014	0.00%
Aug 31, 2014	-250.00%
May 31, 2014	450.85%
Feb 28, 2014	112.10%
Nov 30, 2013	-50.00%
Aug 31, 2013	-300.00%
May 31, 2013	200.00%
Feb 28, 2013	-133.33%
Nov 30, 2012	-25.00%
Aug 31, 2012	300.00%
May 31, 2012	-66.67%
Feb 29, 2012	0.00%
Nov 30, 2011	50.00%
Aug 31, 2011	100.00%
May 31, 2011	0.00%
Feb 28, 2011	137.54%